The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial
van Setten, G.-B.; Baudouin, C.; Horwath-Winter, J.; Böhringer, D.; Stachs, O.; Toker, E.; Al-Zaaidi, S.; Benitez-del-Castillo, J.M.; Beck, R.; Al-Sheikh, O.; Seitz, B.; Barabino, S.; Reitsamer, H.A.; Müller-Lierheim, W.G.K. The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial. J. Clin. Med. 2020, 9, 3536. https://doi.org/10.3390/jcm9113536
van Setten G-B, Baudouin C, Horwath-Winter J, Böhringer D, Stachs O, Toker E, Al-Zaaidi S, Benitez-del-Castillo JM, Beck R, Al-Sheikh O, Seitz B, Barabino S, Reitsamer HA, Müller-Lierheim WGK. The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial. Journal of Clinical Medicine. 2020; 9(11):3536. https://doi.org/10.3390/jcm9113536
Chicago/Turabian Stylevan Setten, Gysbert-Botho, Christophe Baudouin, Jutta Horwath-Winter, Daniel Böhringer, Oliver Stachs, Ebru Toker, Sultan Al-Zaaidi, Jose M. Benitez-del-Castillo, Ria Beck, Osama Al-Sheikh, Berthold Seitz, Stefano Barabino, Herbert A. Reitsamer, and Wolfgang G.K. Müller-Lierheim. 2020. "The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial" Journal of Clinical Medicine 9, no. 11: 3536. https://doi.org/10.3390/jcm9113536